Skip to main content
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. — Investor Relations & Filings

Ticker · VVOS ISIN · US92859E1082 US Manufacturing
Filings indexed 257 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country US United States of America
Listing US VVOS

About Vivos Therapeutics, Inc.

https://vivos.com/

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for sleep-disordered breathing, including obstructive sleep apnea (OSA). The company's core offering is The Vivos System, a non-surgical treatment that uses proprietary oral appliances. These devices are designed to address underlying dentofacial abnormalities that can restrict the airway. The treatment protocol aims to promote the natural growth and development of the jaw and airway in both adult and pediatric patients. Vivos provides its technology and training to a network of licensed dentists and medical professionals who deliver the therapy.

Recent filings

Filing Released Lang Actions
8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)
Regulatory Filings
2026-04-22 English
8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)
Regulatory Filings
2026-04-15 English
10-K - Vivos Therapeutics, Inc. (0001716166) (Filer)
Annual Report FY 2025
2026-04-15 English
8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)
Regulatory Filings
2026-04-03 English
S-3 - VIVOS THERAPEUTICS, INC. (0001716166) (Filer)
Registration Form
2026-02-14 English
3 Filing
Director's Dealing
2026-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.